Array BioPharma Inc. and QLT Inc. entered a deal to create a series of small-molecule therapeutics aimed at cancer targets identified by QLT. QLT, of Vancouver, British Columbia, will be responsible for providing funding based on the number of Array scientists working on the research phase of the agreement. Boulder, Colo.-based Array could receive development milestones and royalties based on sales of products …
No comments:
Post a Comment